Clinical and cytokine responses to house dust mite sublingual immunotherapy

Annals of Allergy, Asthma and Immunology

Volumn 114, Issue 4, 2015, Pages 327-334

  Potter, Paul C ^a   Baker, Sheila ^a   Fenemore, Bartha ^a   Nurse, Barbara ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; GAMMA INTERFERON; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; PLACEBO; ARTHROPOD PROTEIN; CYSTEINE PROTEINASE; CYTOKINE; DERMATOPHAGOIDES PTERONYSSINUS ANTIGEN P 1;

ADULT; ALLERGIC RHINITIS; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DERMATOPHAGOIDES; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; FEMALE; HOUSE DUST ALLERGY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MOUTH EDEMA; ORAL PARESTHESIA; ORAL PRURITUS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRICK TEST; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REGULATORY T LYMPHOCYTE; RHINITIS QUALITY OF LIFE QUESTIONNAIRE; SCORING SYSTEM; SUBLINGUAL IMMUNOTHERAPY; SYMPTOMATOLOGY; TH1 CELL; TH2 CELL; THROAT IRRITATION; TOTAL 5 SYMPTOM SCORE; TREATMENT RESPONSE; URTICARIA; ADOLESCENT; ANIMAL; CELL CULTURE; FOLLOW UP; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PYROGLYPHIDAE; RHINITIS, ALLERGIC; SOUTH AFRICA; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; ARTHROPOD PROTEINS; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PYROGLYPHIDAE; QUALITY OF LIFE; RHINITIS, ALLERGIC; SOUTH AFRICA; SUBLINGUAL IMMUNOTHERAPY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84926406708     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2014.12.015     Document Type: Article

References (41)

1. D.R. Wilson, M. Torres Lima, and S.R. Durham Sublingual immunotherapy for allergic rhinitis: systematic review and meta- analysis Allergy 60 2005 4 12
2. 2LEN meta-analysis Allergy 64 2009 1570 1579
3. S. Radulovic, D. Wilson, M. Calderon, and S. Durham Systematic reviews of sublingual immunotherapy (SLIT) Allergy 66 2011 740 752
4. S.M. Walker, S.R. Durham, and S.J. Till Immunotherapy for allergic rhinitis Clin Exp Allergy 41 2011 1177 1200
5. M. Penago, E. Compelati, and F. Tarantini Efficacy for sublingual immunotherapy in the treatment of allergic rhinitis in paediatric patients 3-18 years of age: a meta analysis of randomised controlled double blind trials Ann Asthma Immunol 97 2006 141 148
6. G.W. Canonica, J. Bousquet, and T. Casale Sublingual immunotherapy: World Allergy Organization Position Paper 2009 Allergy 64 suppl 91 2009 1 59
7. B. Mortemousque, F. Bertel, J. De Casamayor, P. Verin, and J. Colin House dust mite sublingual swallow immunotherapy in perennial conjunctivitis: a double blind placebo controlled study Clin Exp Allergy 33 2003 464 469
8. G. Passalacqua, M. Pasquali, and R. Anano Randomised double blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites Allergy 61 2006 849 864
9. S. Guez, C. Vatrinet, R. Fadel, and C. Andre House dust mite sublingual swallow immunotherapy in perennial rhinitis: a double blind placebo controlled study Allergy 55 2000 369 375
10. G.W. Canonica, C.E. Baena Cagnani, and J. Bousquet Recommendations for standardisation of clinical trials with allergen specific immunotherapy for respiratory allergy: a statement of a World Allergy Organization (WAO) Task Force Allergy 62 2007 317 324
11. E.F. Juniper, and G.H. Guyatt Development and testing of a new measure of health status for clinical trials in rhino conjunctivitis Clin Exp Allergy 21 1991 71 83
12. B. Nurse, A.S. Puterman, M. Haus, D. Berman, E.G. Weinberg, and P.C. Potter PBMC's from both atopic asthmatic and non- atopic children show a TH2 cytokine response to house dust mite allergen J Allergy Clin Immunol 106 2000 84 91
13. P. Moingeon, T. Batard, R. Fadel, F. Frati, J. Sieber, and L. Van Overtvelt Immune mechanisms of allergen-specific sublingual immunotherapy Allergy 61 2006 151 165
14. E. Maggi T cell responses induced by allergen-specific immunotherapy Clin Exp Immunol 161 2010 10 18
15. M.H. Shamji, and S.R. Durham Mechanisms of immunotherapy to aeroallergens Clin Exp Allergy 41 2011 1235 1246
16. C. Antúnez, C. Mayorga, J.L. Corzo, A. Jurado, and M.J. Torres Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy: comparison with subcutaneous administration Pediatr Allergy Immunol 19 2008 210 218
17. A.O. Eifan, T. Akkoc, and A. Yildiz Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial Clin Exp Allergy 40 2010 922 932
18. R.E. O'Hehir, L.M. Gardner, and M.P. de Leon House dust mite sublingual immunotherapy: the role for transforming growth factor-beta and functional regulatory T cells Am J Respir Crit Care Med 180 2009 936 947
19. 2 lymphocytes in asthmatic children treated with Dermatophagoides pteronyssinus immunotherapy Pediatr Allergy Immunol 16 2005 603 608
20. L.M. Gardner, F.C. Thien, J.A. Douglass, J.M. Rolland, and R.E. O'Hehir Induction of T 'regulatory' cells by standardized house dust mite immunotherapy: an increase in CD4+ CD25+ interleukin-10+ T cells expressing peripheral tissue trafficking markers Clin Exp Allergy 34 2004 1209 1219
21. W. Wei, Y. Liu, and Y. Wang Induction of CD4+CD25+Foxp3+IL-10+ T cells in HDM-allergic asthmatic children with or without SIT Int Arch Allergy Immunol 153 2010 19 26
22. C. Möbs, C. Slotosch, H. Löffler, T. Jakob, M. Hertl, and W. Pfützner Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation J Immunol 184 2010 2194 2203
23. K. Nieminen, K. Laaksonen, and J. Savolainen Three-year follow-up study of allergen-induced in vitro cytokine and signaling lymphocytic activation molecule mRNA responses in peripheral blood mononuclear cells of allergic rhinitis patients undergoing specific immunotherapy Int Arch Allergy Immunol 150 2009 370 376
24. B. Bohle, T. Kinaciyan, M. Gerstmayr, A. Radakovics, B. Jahn-Schid, and C. Ebner Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance and immune deviation J Allergy Clin Immunol 120 2007 707 713
25. C. Rolinck-Werninghaus, M. Kopp, C. Liebke, J. Lange, U. Wahn, and B. Niggemann Lack of detectable alterations in immune responses during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen Int Arch Allergy Immunol 136 2005 134 141
26. + T cells by grass pollen immunotherapy J Allergy Clin Immunol 111 2003 1255 1261
27. V. Schulten, V. Tripple, and J. Sidney Association between specific timothy grass antigens and changes in T1- and T2-cell responses following specific immunotherapy J Allergy Clin Immunol 134 2014 1076 1083
28. P.A. Wachholz, K.T. Nouri-Aria, and D.R. Wilson Grass pollen immunotherapy for hayfever is associated with increases in local nasal but not peripheral Th1:Th2 cytokine ratios Immunology 105 2002 56 62
29. M. Jutel, M. Akdis, and F. Budak IL-10 and TGF-β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy Eur J Immunol 33 2003 1205 1214
30. 1 in T cell clones specific for Phi p 1, a major grass pollen allergen Clin Exp Allergy 27 1997 1007 1015
31. C. Fanta, B. Bohle, and W. Hirt Systemic immunological changes induced by administration of grass pollen allergens via the oral mucosa during sublingual immunotherapy Int Arch Allergy Immunol 120 1999 218 224
32. S.E. Burastero, G. Mistrello, and P. Falagiani Effect of sublingual immunotherapy with grass monomeric allergoid on allergen-specific T-cell proliferation and interleukin 10 production Ann Allergy Asthma Immunol 100 2008 343 350
33. L. Cosmi, V. Santarlasci, and R. Angeli Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production Clin Exp Allergy 36 2006 261 272
34. F. Ippoliti, W. De Santis, and A. Volterrani Psychological stress affects response to sublingual immunotherapy in asthmatic children allergic to house dust mite Pediatr Allergy Immunol 17 2006 337 345
35. G. Passalacqua, M. Albano, and L. Fregonese Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite induced rhinoconjunctivitis Lancet 351 1998 629 632
36. J. Bousquet, P. Scheinmann, and M.T. Guinnepain Sublingual swallow immunotherapy (SLIT) in patients with asthma due to house dust mites: a double blind placebo controlled study Allergy 54 1999 249 260
37. A. Didier, H.J. Malling, and M. Worm Optimal dose, efficacy and safety of once daily sublingual immunotherapy with a 5 grass pollen tablet for seasonal allergic rhinitis J Allergy Clin Immunol 120 2007 1338 1345
38. R. Dahl, A. Kapp, and G. Colombo Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years J Allergy Clin Immunol 121 2008 512 518
39. T. Bieber, and H.U. Simon Allergen-specific immunotherapy: current concepts and future directions [editorial] Allergy 66 2011 709 712
40. C. André, M. Perrin-Fayolle, and M. Grosclaude A double-blind placebo-controlled evaluation of sublingual immunotherapy with a standardized ragweed extract in patients with seasonal rhinitis evidence for a dose-response relationship Int Arch Allergy Immunol 131 2003 111 118
41. A. Frew Sublingual immunotherapy N Engl J Med 358 2008 2259 2264